Uncategorized

Mytos Announces Strategic Partnerships with StemSight, Rinri Therapeutics, and Novadip to Power Next-Generation Cell Therapy Trials

by Business Wire • 2025/09/03 • 0 Comments

LONDON--(BUSINESS WIRE)-- #automation--Mytos Announces Strategic Partnerships with StemSight, Rinri Therapeutics, and Novadip to Power Next-Generation Cell Therapy Trials

← Skill in art, science of ocular surface disease needed for successful treatment

OpZira, Inc. Launches to Advance Ophthalmic Diagnostics with Innovative Medical Device Portfolio →

Post navigation